Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 7 Ovarian Neoplasms 5 Papillomavirus Infections 2 Neoplasms 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Uterine Cervical Dysplasia 1 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Squamous Intraepithelial Lesions 1 Sezary Syndrome 1 Recurrence 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1

Interventions

Carboplatin 19 Paclitaxel 17 Cisplatin 9 Gemcitabine 7 Cyclophosphamide 7 Bevacizumab 6 Topotecan 5 pembrolizumab 4 olaparib 4 liposomal doxorubicin 4 durvalumab 4 Letrozole 4 Interleukin-2 4 Drug Therapy 4 Doxorubicin 4 Albumin-Bound Paclitaxel 4 rucaparib 3 fludarabine 3 chiauranib 3 cemiplimab 3 camrelizumab 3 Therapeutics 3 Itraconazole 3 Injections 3 Hyperthermic Intraperitoneal Chemotherapy 3 Everolimus 3 pazopanib 2 iniparib 2 eprenetapopt 2 avelumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Data Collection × Gynecologic × Clear all

NCT02262273 2017-03-01

OSCA

AstraZeneca

Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡